Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era

PURPOSE: Statins have antilymphoma properties but have also been shown to inhibit the binding of rituximab to the CD20 antigen, resulting in reduced antitumor activity of rituximab in vitro. The clinical impact of statin use on the outcome of lymphoma patients treated with a rituximab-containing reg...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Nowakowski, Grzegorz S., Maurer, Matthew J., Habermann, Thomas M., Ansell, Stephen M., Macon, William R., Ristow, Kay M., Allmer, Cristine, Slager, Susan L., Witzig, Thomas E., Cerhan, James R.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2010
נושאים:
Original Reports
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815703/
https://ncbi.nlm.nih.gov/pubmed/20008638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.23.4245
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים